Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children

Pediatric Dermatology

Volumn 14, Issue 1, 1997, Pages 46-48

  Dragoš, Vlasta ^a   Lunder, Majda ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

TERBINAFINE;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MICROSPORUM CANIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TINEA CAPITIS; TREATMENT FAILURE;

EID: 0031041392     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.1997.tb00427.x     Document Type: Article

References (23)

1. Caprilli F, Mercantini R, Palamara G, Belardi M, Crescimbeni E. Distribution and frequency of dermatophytes in the city of Rome 1978-1983. Mycosen 1987;30:86-93.
2. Difonzo EM, Palleschi GM, Gauardagni R, Vannini P, Battini ML. Epidemiology of dermatophytes in Florence area 1982-1984. Microsporum canis infections. Mycosen 1986; 29:519-525.
3. Martinez-Roig A, Torres-Rodriquez JM. Dermatophytosis in children and adolescents. Epidemiological study in the city of Barcelona, Spain. Mycosen 1986;29:311-315.
4. Torok I, Simon G, Pap M. Microsporum canis infection in Hungary. Mycosen 1982;25:42-46.
5. Lunder M, Lunder M. Is Microsporum canis infection about to become a serious dermatological problem? Dermatology 1992;184:87-89.
6. Hurwitz S. Skin disorders due to fungi. In: Hurwitz S. Clinical Pediatric Dermatology. 2nd ed. Philadelphia: WB Saunders, 1993:374-378.
7. Keipert JA. Beneficial effect of corticosteroid therapy in Microsporum canis kerion. Aust J Dermatol 1984;25: 127-130.
8. Ryder NS. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimicotic agent. Antimicrob Agents Chemother 1985;27:252-256.
9. Ryder NS. The mechanism of action of terbinafie. Clin Exp Dermatol 1989;14:98-100.
10. Rakosi T, Wili PB, Kenzelmann R. Treatment of onychomycosis with terbinafine. Br J Dermatol 1992;126(suppl 39):40-46.
11. Goodfield MJD. Short duration therapy for dermatophyte onychomycosis: a multicenter trial. Br J Dermatol 1992; 126(suppl 39):33-35.
12. Villars V, Jones TC. Clinical efficacy and tolerability of terbinafine (Lamisil): a new topical and systemic fungicidal drug for treatment of dermatomycosis. Clin Exp Dermatol 1989;14:124-127.
13. Villars V, Jones TC. Present status of the efficacy and tolerability of terbinafine (Lamisil) used systemically in the treatment of dermatomycosis of skin and nails. J Dermatol Treat 1990:1(suppl 2):33-38.
14. Ganzinger U, Stutz A, Petranyi G, et al.Allylamines:topical and oral treatment of dermatomycosis with a new class of antifugal agents. Acta Derm Venereol suppl. (Stockhl) 1986;121:155-160.
15. Jones TJ. Overview of the use of terbinafine (Lamisil) in children. Br J Dermatol 1995;132:683-689.
16. Clayton YM. In vitro activity of terbinafine. Clin Exp Dermatol 1989;14:101-103.
17. Petranyi G, Meingasser JG, Micth H. Antifungal activity of the allylamme derivate terbinafine in vitro. Antimicrob Agent Chemother 1987;31:1365-1368.
18. Elewski BE. Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol 1993;28:S28-S34.
19. Faergemann J, Zehendar H, Denouel J, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis, epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally per day for four weeks. Acta Dermatol Venereol (Stockh) 1993;73:305-309.
20. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis, epidermis (without stratum corneum), sebum, hairs and nails during and after 250 mg terbinafine orally and daily for 7-14 days. Clin Exp Dermatol 1994;19:121-126.
21. Haroon TS, Hussain I, Mahmood A, et al. An open clinical pilot study of efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Br J Dermatol 1992;126 (suppl 39):47-50.
22. Nejjam F, Zagula M, Cabiac MD, et al. Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol 1995;132:98-105.
23. Goulden V, Goodfield MJD. Treatment of childhood dermatophyte infection with oral terbinafine. Pediatr Dermatol 1995;12:53-54.